comparemela.com

Latest Breaking News On - Arcturus therapeutics - Page 1 : comparemela.com

Vertex: Poised For Long-Term Growth Driven By Multiple Pipeline Catalysts

Vertex: Poised For Long-Term Growth Driven By Multiple Pipeline Catalysts
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Brazil
Bahrain
United-states
American
Reshma-kewalramani
Trikafta-kaftrio
Kalydeco-ivacaftor
Stuart-arbuckle
Povetacicept-pove
William-blair
Vertex-pharmaceuticals

Arcturus Therapeutics (NASDAQ:ARCT) Trading 5.8% Higher

Arcturus Therapeutics (NASDAQ:ARCT) Trading 5.8% Higher
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

William-blair
Kokusai-asset-management-co
Barclays-plc
York-mellon-corp
Mitsubishi-ufj
Commonwealth-equity-services
Citigroup
Arcturus-therapeutics-holdings-inc
Nasdaq
Canaccord-genuity-group
Arcturus-therapeutics-company-profile
Arcturus-therapeutics-holdings

Analysts Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) PT at $64.86

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned a consensus rating of “Buy” from the seven brokerages that are covering the company, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued a report on the […]

William-blair
Capital-management
Canaccord-genuity-group
Arcturus-therapeutics-holdings-inc
Allspring-global-investments-holdings
Securities-exchange-commission
Citigroup
Blair-william-co
Nasdaq
Arcturus-therapeutics-company-profile
Jupiter-asset-management-ltd
Schonfeld-strategic-advisors

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Rating of "Buy" by Brokerages

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been given an average rating of “Buy” by the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the […]

New-york
United-states
Ohio
William-blair
Russell-investments-group-ltd
Arcturus-therapeutics-holdings-inc
Canaccord-genuity-group
Securities-exchange-commission
Quest-partners
Nasdaq
Citigroup
Arcturus-therapeutics-holdings

Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine

Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Japan
China
California
United-states
Australia
San-diego
Jimmy-baker
Jon-edelman
Neda-safarzadeh
Kim-odonohue
Mrna-technology
Nature-communications

vimarsana © 2020. All Rights Reserved.